Solence key facts
as of Oct 2026- Developer of a digital health support tool designed to manage chronic hormonal conditions.
- Solence is valued at approximately $6.9M as of Oct 2026 (last reported valuation).
- It has raised $2.1M; the latest was Seed Round ($1.9M) in Jul 2025.
- Notable investors include Bpifrance, Celine Lazorthes, Berthe Latreille, Impact Shakers, Impact Shakers Ventures — 8 tracked in total.
- Status: Privately Held (backing).
Solence's last reported valuation, Jul 2025. Nothing priced has surfaced since.
- ·Watch Solence: the Monday email on marks, rounds and moves
Solence funding rounds
No funding rounds for Solence are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Solence valuation
Solence's last reported valuation was $6.9 million in Jul 2025. No priced round, secondary trade or fund mark has surfaced since.
Solence investors
8 investors are on record for Solence, including Bpifrance, Celine Lazorthes, Berthe Latreille and Impact Shakers.
About Solence
Developer of a digital health support tool designed to manage chronic hormonal conditions. The company offers a personalized program that combines educational content, lifestyle tracking, symptom monitoring, and behavioral guidance of polycystic ovary syndrome, enabling women to better understand and manage their condition through structured routines and habit-building strategies.
- Sector
- Healthcare
- HQ
- Strasbourg, France
- Founded
- 2022
- Employees
- 8
- Website
- solence.care/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.